HCM SEC Filings: 8-K, 10-Q, S-3 & 424B – HUTCHMED (China)

Financials

TYPE

HEADLINE

FILED AT

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 5, 2026

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 19, 2025

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Feb 28, 2024

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Feb 28, 2023

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 3, 2022

20-F

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Mar 4, 2021

News

TYPE

HEADLINE

FILED AT

6-K

HUTCHMED's Sovleplenib Granted US FDA Orphan Drug Designation for Autoimmune Hemolytic Anemia

Nov 5, 2026

6-K

HUTCHMED Announces Regulatory Filings Accepted for Review for ORPATHYS plus TAGRISSO in MET-Driven EGFR-Mutated Lung Cancer in Europe and Japan

Nov 2, 2026

6-K

HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Primary Immune Thrombocytopenia

Oct 29, 2026

6-K

HUTCHMED to Host Expert Insights Event on Recent Savolitinib Clinical Data in Non-Small Cell Lung Cancer

Oct 27, 2026

6-K

HUTCHMED Highlights Positive SAFFRON Global Phase III Trial Results for ORPATHYS Plus TAGRISSO in Lung Cancer

Oct 26, 2026

6-K

HUTCHMED Closes KRAS-EGFR-Antibody Conjugate Therapy License Agreement with GSK

Oct 21, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

40,784,500 Ordinary Shares-

Jun 24, 2021

424B5

104,000,000 Ordinary Shares-

Jun 21, 2021

424B3

Registration-

May 14, 2021

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Jan 23, 2020

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Jan 21, 2020

424B7

Form 424B7 - Prospectus [Rule 424(b)(7)]

Sep 30, 2019

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jun 9, 2026

F-3ASR

Form F-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers

Jun 28, 2024

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jul 30, 2020

F-3ASR

Form F-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers

Apr 6, 2020

FWP

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Sep 30, 2019

F-6 POS

Form F-6 POS - Post-effective amendments for immediately effective filing

May 29, 2019

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

Cheng Chig Fung (Reporting)

May 21, 2026

Nixon Charles George Rupert (Reporting)

May 21, 2026

Su Wei-guo (Reporting)

May 21, 2026

Chiu Lorenso (Reporting)

May 21, 2026

Mok Tony Shu Kam (Reporting)

May 13, 2026

Nixon Charles George Rupert (Reporting)

Mar 31, 2026

Other

TYPE

HEADLINE

FILED AT

HUTCHMED (China) Limited HCM · SEC Filings